Guided Therapy

DEVICE2 trials

Sponsors

Giselle Sholler

Conditions

Choroid Plexus NeoplasmsClear Cell SarcomaCraniopharyngiomaDysembryoplastic Neuroepithelial TumorEpendymomaEwings SarcomaGerm Cell TumorsGlioma

Unknown Phase

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

CompletedNCT01355679

Giselle ShollerNeuroblastoma

Start: 2011-05-31End: 2015-01-31Updated: 2024-08-06

Molecular-Guided Therapy for Childhood Cancer

CompletedNCT02162732

Giselle ShollerChoroid Plexus Neoplasms, Clear Cell Sarcoma, Craniopharyngioma +16

Start: 2014-07-08End: 2024-01-18Updated: 2025-11-03

Related Papers

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report

Frontiers in Oncology2026-07-14

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.

2024-02-126 citations

Integrated whole-exome and transcriptome analysis of 250 treatment-refractory or relapsed (R/R) childhood solid tumors.

Journal of Clinical Oncology2021-05-20